DEMOGRAPHIC DETAILS AGE : 40 GENDER : male REASON FOR ADMISSION : complaints of giddiness(since 2 days),mild chest discomfort (since 2 days) PAST MEDICAL HISTORY : Known case of hypertension PAST MEDICATION HISTORY : Tab. Chlorothiazide Tab. Telmisartan Tab. Spirinolactone
VITAL SIGNS DATE 5/9/19 6/9/19 TEMP N N BLOOD PRESSURE 200/100 mmHG 130/80 mmHG PULSE RATE 121 BPM 102 BPM RESPIRATORY RATE N N
LABORATORY INVESTIGATION TEST TEST VALUE NORMAL VALUE RBS 141 70-140 mg/dl RDW 15 11.6-14% TLC 11.2 4.5-11.0 X 10 9 /L LYMPHOCYTE 9.6 20-40% NEUTROPHILES 79.1 40-75%
DIAGNOSIS Accelerated hypertension U nstable angina
PHARMACEUTICAL CARE PLAN THE TREATMENT GOAL : To reduce the chest discomfort To reduce the increased blood pressure towards normal To reduce giddiness
DRUG RELATED PROBLEM SL.NO DRUG- DRUG INTERACTION SEVERITY EFFECTS 1 NEBIVOLOL + AMLODIPIN MODERATE BP AND HR 2 TORESIMIDE + NEBIVOLOL MODERATE HYPERKALEMIA
SL.NO DRUG NAME SIDE EFFECTS 1 AMLODIPIN DIZZINESS, LIGHTHEADEDNESS 2 NITROGLYCERIN ORTHOSTATIC HYPOTENSION 3 TORESIMIDE MUSCLE CRAMPS, UNSUAL DRY MOUTH 4 ISOLAZINE LOSS OF APPETITE 5 NEBIVOLOL PEDAL EDEMA, SHORTNESS OF BREATH 6 BETAHISTIDINE STOMACH UPSET, HEADACHE 7 TELMISARTAN CHANGES OF VISION, CHANGES IN URINATION FREQUENCY
MONITORING PARAMETERS Monitor for blood pressure Monitor blood parameters Monitor for any further complication and comorbid diseases
PATIENT EDUCATION Educate on importance of patient compliance Emphasize that nitroglycerin must be kept in an dark container, away from heat or moisture Review direction on using NTG preventively that is should be taken 5 min before physical activity Warn the patient about Beta-blockers withdrawal Encourage smoking cessation for patient who smoke Proper diet, Recommend about DASH(Dietary associated to Stop Hypertension), proper exercise, weight reduction.
DISCHARGE MEDICATION SL.NO DRUGS DOSE AND DAYS 1 AMLODIPIN 5mg (OD) {MORNING, AFTER FOOD} 2 NEBIVOLOL 5mg (OD) 3 TELMISARTAN 40mg (OD) 4 BETAHISTIDINE 8mg (BD) {3DAYS, AFTER FOOD}